← back to search

Therése Andersson

Karolinska Institutet · SE
Area of research
Oncology · Education
Research interest
Research interests include Global Cancer Incidence and Screening, Social and Educational Sciences, Statistical Methods and Inference, and Colorectal Cancer Screening and Detection.
h-index
52
citations
11,186
works
372
NIH funding
primary concept
email

Recent publications

The long-lasting impacts of the COVID-19 pandemic on population-based cancer survival: what are the implications for data analysis?
British Journal of Cancer 2024cited by 9position: middledoi
Standardised survival probabilities: a useful and informative tool for reporting regression models for survival data
British Journal of Cancer 2022cited by 40position: lastdoi
Self-reported arm and shoulder problems in breast cancer survivors in Sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort study
Breast Cancer Research 2021cited by 9position: middledoi
A way to explore the existence of “immortals” in cancer registry data – An illustration using data from ICBP SURVMARK-2
Cancer Epidemiology 2021cited by 4position: firstdoi
Cancer survival statistics for patients and healthcare professionals – a tutorial of real‐world data analysis
Journal of Internal Medicine 2020cited by 108position: lastdoi
Trends in cancer survival in the Nordic countries 1990–2016: the NORDCAN survival studies
Acta Oncologica 2020cited by 76position: middledoi
Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden
Scandinavian Journal of Urology 2020cited by 63position: middledoi
Incidence of myeloproliferative neoplasms – trends by subgroup and age in a population‐based study in Sweden
Journal of Internal Medicine 2020cited by 61position: lastdoi
Risk of infections in patients with myeloproliferative neoplasms—a population-based cohort study of 8363 patients
Leukemia 2020cited by 54position: middledoi
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
The Lancet Oncology 2019cited by 1,038position: middledoi
Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms
Annals of Internal Medicine 2018cited by 256position: lastdoi
Cubosomes for topical delivery of the antimicrobial peptide LL-37
European Journal of Pharmaceutics and Biopharmaceutics 2018cited by 177position: middledoi
Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients
Leukemia 2018cited by 91position: middledoi
Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden
Journal of Affective Disorders 2018cited by 91position: middledoi
Tumor characteristics and prognosis in women with pregnancy‐associated breast cancer
International Journal of Cancer 2017cited by 109position: middledoi
Estimating the impact of a cancer diagnosis on life expectancy by socio-economic group for a range of cancer types in England
British Journal of Cancer 2017cited by 65position: middledoi
Clinical Diagnosis of Mental Disorders Immediately Before and After Cancer Diagnosis
JAMA Oncology 2016cited by 220position: middledoi
Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life
Blood Cancer Journal 2016cited by 65position: middledoi
Cancer during pregnancy and the postpartum period: A population‐based study
Cancer 2015cited by 143position: firstdoi
Mortality in women with pregnancy-associated malignant melanoma
Journal of the American Academy of Dermatology 2014cited by 64position: middledoi
Aspirin intake and breast cancer survival – a nation-wide study using prospectively recorded data in Sweden
BMC Cancer 2014cited by 44position: middledoi
Survival and cure of acute myeloid leukaemia in <scp>E</scp>ngland, 1971‐2006: a population–based study
British Journal of Haematology 2013cited by 208position: middledoi
Estimating the loss in expectation of life due to cancer using flexible parametric survival models
Statistics in Medicine 2013cited by 157position: firstdoi
Stage at diagnosis and mortality in women with pregnancy-associated breast cancer (PABC)
Breast Cancer Research and Treatment 2013cited by 69position: middledoi
Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based Study
Journal of Clinical Oncology 2012cited by 216position: middledoi
Screening and cervical cancer cure: population based cohort study
BMJ 2012cited by 210position: middledoi
Patterns of survival in lymphoplasmacytic lymphoma/waldenström macroglobulinemia: A population‐based study of 1,555 patients diagnosed in Sweden from 1980 to 2005
American Journal of Hematology 2012cited by 69position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Paul W. Dickman · Karolinska Institutet11 papers (2012–2020)Paul C. Lambert · Norwegian Institute of Public Health9 papers (2012–2024)Magnus Björkholm · Svenska Örtmedicinska Institute8 papers (2012–2020)Mats Lambe · Karolinska Institutet6 papers (2013–2020)Sandra Eloranta · Karolinska Institutet6 papers (2012–2020)Anna L.V. Johansson · Karolinska Institutet5 papers (2013–2020)Sigurður Y. Kristinsson · Reykjavík University5 papers (2012–2020)Malin Hultcrantz · Memorial Sloan Kettering Cancer Center5 papers (2012–2020)Hannah Bower · Karolinska Institutet3 papers (2016–2018)Ola Landgren · Miami University3 papers (2012–2018)Mark J. Rutherford · University of Leicester3 papers (2017–2024)Karin E. Smedby · Karolinska University Hospital3 papers (2014–2020)Åsa Rangert Derolf · Karolinska University Hospital3 papers (2012–2018)Jan Samuelsson · Linköping University Hospital3 papers (2018–2020)Anna Ravn Landtblom · Karolinska University Hospital3 papers (2018–2020)Sven Cnattingius · Karolinska Institutet2 papers (2013–2017)Chung-Cheng Hsieh · Harvard University2 papers (2013–2017)Irma Fredriksson · Karolinska University Hospital2 papers (2015–2017) · 2 papers (2020–2021)Karin Jirström · Lund University2 papers (2013–2017)